Sanofi exercises license extension option to Nurix’s STAT6 program
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
The CDMO upgrade represents a transformational step for Remedium Lifecare
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The change of name has been carried on pursuant to the Scheme of Amalgamation
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Subscribe To Our Newsletter & Stay Updated